Abstract:
The surging prevalence of diabetes globally necessitates advancements in non-invasive diagnostics, particularly for the early detection of cardiovascular anomalies associated with the condition. This study explores the efficacy of Pulse Wave Analysis (PWA) for distinguishing diabetic from non-diabetic individuals through morphological examination of pressure pulse waveforms. The research unfolds in four phases: data accrual, preprocessing, Convolutional Neural Network (CNN) model construction, and performance evaluation. Data were procured using a multipara patient monitor, resulting in 2000 pulse waves equally divided between healthy individuals and those with diabetes. These were used to train, validate, and test three distinct CNN architectures: the conventional CNN, Visual Geometry Group (VGG16), and Residual Networks (ResNet18). The accuracy, precision, recall, and F1 score gauged each model’s proficiency. The CNN demonstrated a training accuracy of 82.09% and a testing accuracy of 80.6%. The VGG16, with its deeper structure, surpassed the baseline with training and testing accuracies of 90.2% and 86.57%, respectively. ResNet18 excelled, achieving a training accuracy of 92.50% and a testing accuracy of 92.00%, indicating its robustness in pattern recognition within pulse wave data. Deploying deep learning for diabetes screening marks progress, suggesting clinical use and future studies on bigger datasets for refinement.
